MedTrace Logo

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

NCT06340646 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 990

Last updated 2025-07-11

No results posted yet for this study

Summary

The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches that direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research, and to investigate the impact of directly engaging participants in decisions regarding returning of genomic results on participants' health and satisfaction. Participants in this study will be presented with the choice of types of genomic results to receive, and the Engagement Optimization Unit (EOU) will investigate the impact of this intervention on participant knowledge, expectations of benefit, personal utility, and decisional conflict.

Conditions

Interventions

OTHER

Return of Genetic Results: Biomarker information from cancer cells

Participants will receive a novel return of results report that is tailored to their choices.

OTHER

Return of Genetic Results: Inherited mutations related to cancer

Participants will receive a novel return of results report that is tailored to their choices.

OTHER

Return of Genetic Results: Inherited mutations related to other medical issues

Participants will receive a novel return of results report that is tailored to their choices.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • The Foundation for Barnes-Jewish Hospital

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Graham Colditz, M.D., DrPH, MPH · Washington University School of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-18
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06340646 on ClinicalTrials.gov